S

Shandong Taihe Water Treatment Technologies Co Ltd
SZSE:300801

Watchlist Manager
Shandong Taihe Water Treatment Technologies Co Ltd
SZSE:300801
Watchlist
Price: 16.32 CNY -3.94% Market Closed
Market Cap: 3.6B CNY
Have any thoughts about
Shandong Taihe Water Treatment Technologies Co Ltd?
Write Note

Shandong Taihe Water Treatment Technologies Co Ltd
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shandong Taihe Water Treatment Technologies Co Ltd
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Taihe Water Treatment Technologies Co Ltd
SZSE:300801
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai Putailai New Energy Technology Co Ltd
SSE:603659
Other Equity
ÂĄ2m
CAGR 3-Years
262%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Wanhua Chemical Group Co Ltd
SSE:600309
Other Equity
-ÂĄ516.3m
CAGR 3-Years
N/A
CAGR 5-Years
-33%
CAGR 10-Years
-52%
Hoshine Silicon Industry Co Ltd
SSE:603260
Other Equity
ÂĄ71.4m
CAGR 3-Years
N/A
CAGR 5-Years
135%
CAGR 10-Years
N/A
C
CNGR Advanced Material Co Ltd
SZSE:300919
Other Equity
ÂĄ271.6m
CAGR 3-Years
1 007%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tianqi Lithium Corp
SZSE:002466
Other Equity
ÂĄ1.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shandong Taihe Water Treatment Technologies Co Ltd
Glance View

Market Cap
3.4B CNY
Industry
Chemicals

Shandong Taihe Water Treatment Technologies Co., Ltd. engages in the research, development, production, and sale of water treatment agents. The company is headquartered in Zaozhuang, Shandong and currently employs 653 full-time employees. The company went IPO on 2019-11-28. The firm's products include scale inhibitors, corrosion inhibitors, biocides & algicides, chelating agents, dispersing agents, reverse osmosis agents, detergent auxiliaries etc. The firm conducts its businesses within the domestic market and to overseas markets.

Intrinsic Value
10.02 CNY
Overvaluation 39%
Intrinsic Value
Price
S

See Also

Back to Top